Argenica Therapeutics Limited (ASX:AGN)
0.0700
-0.0300 (-30.00%)
Nov 20, 2026, 2:05 PM AEDT
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 8.99 million as of November 19, 2026. It is the 43,795th most valuable company in the world and the 1,324th biggest in Australia. Its market cap has decreased by 68.18% in one year.
Market Cap
8.99M
Enterprise Value
2.63M
Revenue
5.48M
Global Rank
Country Rank
#1,324 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has decreased from 19.02M to 8.99M, a decrease of -52.74%. That is a compound annual growth rate of -12.85%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 8.99M | -76.27% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Miro Sciences | 16.76M |
| Proteomics International Laboratories | 15.55M |
| Imugene | 15.18M |
| Ceryvyn Therapeutics | 15.05M |
| EZZ Life Science Holdings | 13.65M |
| Radiopharm Theranostics | 13.01M |
| Patrys | 12.81M |
| ReNerve | 12.06M |